| Diff4VS: HIV-inhibiting Molecules Generation with Classifier Guidance Diffusion for Virtual Screening | Jul 20, 2024 | Drug Design | CodeCode Available | 0 |
| Decomposed Direct Preference Optimization for Structure-Based Drug Design | Jul 19, 2024 | Drug Design | —Unverified | 0 |
| Antibody DomainBed: Out-of-Distribution Generalization in Therapeutic Protein Design | Jul 15, 2024 | Domain GeneralizationDrug Design | —Unverified | 0 |
| Token-Mol 1.0: Tokenized drug design with large language model | Jul 10, 2024 | Drug DesignDrug Discovery | —Unverified | 0 |
| Leveraging Latent Evolutionary Optimization for Targeted Molecule Generation | Jul 2, 2024 | Drug DesignDrug Discovery | —Unverified | 0 |
| DCI: An Accurate Quality Assessment Criteria for Protein Complex Structure Models | Jun 30, 2024 | Drug Design | —Unverified | 0 |
| YZS-model: A Predictive Model for Organic Drug Solubility Based on Graph Convolutional Networks and Transformer-Attention | Jun 27, 2024 | Drug DesignDrug Discovery | CodeCode Available | 0 |
| Molecular Diffusion Models with Virtual Receptors | Jun 26, 2024 | Drug DesignProtein Folding | —Unverified | 0 |
| A Comprehensive Review of Emerging Approaches in Machine Learning for De Novo PROTAC Design | Jun 24, 2024 | Drug DesignDrug Discovery | —Unverified | 0 |
| Explainable Machine Learning and Deep Learning Models for Predicting TAS2R-Bitter Molecule Interactions | Jun 21, 2024 | Drug DesignExplainable Models | —Unverified | 0 |
